搜索结果 | 泌尿系统常见疾病循证医学证据

证据分类

搜索结果

共搜索到299条与D.有关的结果

Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

 2022 年发布于 Int J Nurs Pract 13 卷第 4 期

Garcia-Rojo D. Munoz-Rodriguez J. Centeno C. Dominguez A. Prera A. Abad C. Vicente E. Gonzalez-Sala J. L. Hannaoui N. Capdevila M. De Verdonces L. Ferran A. Pla C. Azuara P. Cuadrench S. Zegri M. E. Prats J.

非肌层浸润性膀胱癌卡介苗维持治疗诱导治疗
文献简介 原文链接
The impact of preoperative immune checkpoint inhibitors on kidney and bladder cancer surgeries: a systematic review

 2022 年发布于 Eur Urol Focus 13 卷第 5 期

Petzold A. P. Lubianca F. N. Passos L. G. Keppler C. K. Becker N. B. Viera C. D. Fay A. P. Carvalhal G. F.

Bladder cancer Hpv Human papillomavirus Meta-analysis
文献简介 原文链接
Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis

 2022 年发布于 Frontiers in Oncology 8 卷第 17 期

Mori K. Schuettfort V. M. Yanagisawa T. Katayama S. Pradere B. Laukhtina E. Rajwa P. Mostafaei H. Sari Motlagh R. Quhal F. Moschini M. Soria F. Teoh J. Y. C. D'Andrea D. Abufaraj M. Albisinni S. Krajewski W. Egawa S. Karakiewicz P. I. Rink M. Shariat S. F.

microbiota systematic review urinary bladder neoplasms
文献简介 原文链接
The prognostic value of the Controlling Nutritional Status score on patients undergoing nephrectomy for upper tract urothelial carcinoma or renal cell carcinoma: a systematic review and meta-analysis

 2022 年发布于 Cancers (Basel) 44 卷第 10 期

Chen J. Cao D. Peng Z. Song P. Liu Z. Yang L. Wang L. Zhou J. Wei Q. Dong Q.

Blood Transfusion/*mortality Combined Modality Therapy Cystectomy/*mortality Humans *Perioperative Care Prognosis Survival Rate Urinary Bladder Neoplasms/pathology/*therapy Bladder cancer Blood transfusion Cystectomy Meta-analysis Oncology Systematic review
文献简介 原文链接
From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC)

 2022 年发布于 Cancers (Basel) 44 卷第 3 期

Deininger S. Törzsök P. Mitterberger M. Pallauf M. Oswald D. Deininger C. Lusuardi L.

Bladder cancer Intra-arterial chemotherapy Intravesical chemotherapy Recurrence Survival
文献简介 原文链接
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria

 2022 年发布于 J Endourol 2022 卷第 4 期

Rai B. P. Luis Dominguez Escrig J. Vale L. Kuusk T. Capoun O. Soukup V. Bruins H. M. Yuan Y. Violette P. D. Santesso N. van Rhijn B. W. G. Hugh Mostafid A. Imran Omar M.

bladder cancer gemcitabine intravesical chemotherapy
文献简介 原文链接
En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analyses of Its Differential Effect on Its Safety, Histopathology and, Recurrence

 2022 年发布于 Bladder Cancer 81 卷第 6 期

Yanagisawa T. Mori K. Motlagh R. S. Kawada T. Mostafaei H. Quhal F. Laukhtina E. Rajwa P. Konig F. Pallauf M. Pradere B. D'Andrea D. Comperat E. Miki J. Kimura T. Egawa S. Shariat S. F.

Aged Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Carcinoma Transitional Cell/*drug therapy/*pathology Female Humans Immune Checkpoint Inhibitors/*therapeutic use Liver Neoplasms/secondary Male Middle Aged Survival Analysis Urinary Bladder Neoplasms/*drug therapy/*pathology bladder cancer immune checkpoint inhibitors immunotherapy meta-analysis urothelial carcinoma
文献简介 原文链接
A meta-analysis on the susceptibility to the development of bladder cancer in the presence of DNMT3A, DNMT3B, and MTHFR gene polymorphisms

 2022 年发布于 Urol Oncol 76 卷第 1 期

Touala-Chaila Z. Abderrahmane R. K. Benseddik K. Meroufel D. N.

*Cannabis Humans *Urinary Bladder Neoplasms/epidemiology/etiology
文献简介 原文链接
Prognostic value of programmed cell death ligand-1 expression in patients with bladder urothelial carcinoma undergoing radical cystectomy: A meta-analysis

 2022 年发布于 Eur Radiol 2022 卷第 12 期

Zhang J. Song L. Zhu H. Liu Q. Wang D.

Diet Fruit Humans Male Prospective Studies Risk Risk Factors *Urinary Bladder Neoplasms/epidemiology/etiology *Vegetables
文献简介 原文链接
Safety and efficacy of en bloc vs. conventional transurethral resection of bladder tumors: a meta-analysis and systematic review

 2022 年发布于 Arch Ital Urol Androl 13 卷第 12 期

Oswald D. Pallauf P. Deininger S. Herrmann T. R. W. Netsch C. Becker B. Fiedler M. Haecker A. Homberg R. Klein J. T. Lehrich K. Miernik A. Olbert P. Schob D. S. Sievert K. D. Gross A. J. Westphal J. Lusuardi L.

Humans *Neoplasm Recurrence Local/drug therapy *Urinary Bladder Neoplasms/pathology Infusions Intra-Arterial Chemotherapy Adjuvant Adverse Reactions bladder cancer intra-arterial chemotherapy meta-analysis prognosis
文献简介 原文链接
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis (vol 4, pg 927, 2021)

 2022 年发布于 Int Braz J Urol 40 卷第 1 期

Laukhtina E. Shim S. R. Mori K. D'Andrea D. Soria F. Rajwa P. Mostafaei H. Comperat E. Cimadamore A. Moschini M. Teoh J. Y. C. Enikeev D. Xylinas E. Lotan Y. Palou J. Gontero P. Babjuk M. Witjes J. A. Kamat A. M. Roupret M. Shariat S. F. Pradere B.

Bcg Bacillus Calmette–Guérin Nmibc bladder cancer checkpoint inhibition therapy nadofaragene firadenovec non muscle invasive oncolytic viruses
文献简介 原文链接
Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis

 2022 年发布于 European Urology Focus 94 卷第 5 期

Liu C. Q. Sun J. X. Xu J. Z. Qian X. Y. Hong S. Y. Xu M. Y. An Y. Xia Q. D. Hu J. Wang S. G.

Cystectomy/methods Humans Quality of Life *Urinary Bladder Neoplasms/surgery *Urinary Diversion/methods *Urinary Reservoirs Continent nursing systematic review urinary diversion
文献简介 原文链接
Systematic Review: The Learning Curve for Robot-Assisted Radical Cystectomy-What Do We Know?

 2022 年发布于 Anticancer Research 169 卷第 16 期

Morozov A. Babaevskaya D. Taratkin M. Inoyatov J. Laukhtina E. Moschini M. Singla N. Gomez Rivas J. Teoh J. Y. Glybochko P. Enikeev D.

Female Gene Expression Profiling Gene Regulatory Networks Humans Male Muscles Neoplasm Invasiveness Prognosis *Urinary Bladder Neoplasms/genetics/metabolism rab GTP-Binding Proteins/genetics/metabolism Bladder cancer Gene expression Muscle-invasive bladder cancer Urothelial cancer
文献简介 原文链接
Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis

 2022 年发布于 Bladder Cancer 2022 卷第 5 期

Jazayeri S. B. Dehghanbanadaki H. Hosseini M. Taghipour P. Bazargani S. Thomas D. Feibus A. Sarabchian E. Bacchus M. W. Di Valerio E. A. Bandyk M. Balaji K. C.

Area Under Curve *Carcinoma Transitional Cell Humans In Situ Hybridization Fluorescence ROC Curve Sensitivity and Specificity *Urinary Bladder Neoplasms/pathology Biomarker Cytology Diagnostic Fluorescent in situ hybridization (FISH) Meta-analysis Upper urinary tract urothelial carcinoma (UTUC)
文献简介 原文链接
The clinical efficacy and safety of equipment-assisted intravesical instillation of mitomycin C after transurethral resection of bladder tumour in patients with nonmuscular invasive bladder cancer: A meta-analysis

 2022 年发布于 Int J Urol 86 卷第 1 期

Zhou W. Liu J. Mao D. Hu C. Gao D.

Antibodies Monoclonal Humanized/*therapeutic use *Carcinoma Transitional Cell/drug therapy Humans Prognosis Retrospective Studies *Urinary Bladder Neoplasms/drug therapy Metastatic urothelial carcinoma Pembrolizumab Prognostic factor Janssen and Pfizer. Takahiro Kimura is a paid consultant/advisor of Astellas Bayer Janssen and Sanofi. Shahrokh F. Shariat is a paid as follows: Honoraria: Astellas AstraZeneca Bayer BMS Cepheid Ferring Ipsen Janssen Lilly MSD Olympus Pfizer Pierre Fabre Richard Wolf Roche Sanochemia Sanofi Takeda Urogen. Consulting or Advisory Role: Astellas AstraZeneca Bayer BMS Cepheid Ferring Ipsen Janssen Lilly MSD Olympus Pfizer Pierre Fabre Richard Wolf Roche Sanochemia Sanofi Takeda Urogen. Speakers Bureau: Astellas Astra Zeneca Bayer BMS Cepheid Ferring Ipsen Janssen Lilly MSD Olympus Pfizer Pierre Fabre Richard Wolf Roche Sanochemia Sanofi Takeda Urogen Movember Foundation. The other authors declare no conflicts of interest associated with this manuscript.
文献简介 原文链接
The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis

 2022 年发布于 PLoS One 104 卷第 7 期

Peng L. Meng C. Li J. You C. Du Y. Xiong W. Xia Z. Cao D. Li Y.

Humans Female Male Infant *Urinary Bladder Neoplasms/diagnosis/therapy/pathology *Carcinoma Transitional Cell/pathology Urinary Bladder/pathology Neoplasm Staging Cystoscopy Cystectomy/methods
文献简介 原文链接
Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: A meta-analysis

 2022 年发布于 Int Braz J Urol 82 卷第 7 期

Wang J. Zhao X. Jiang X. L. Lu D. Yuan Q. Li J.

Adjuvants Immunologic Administration Intravesical BCG Vaccine/therapeutic use Bayes Theorem *Covid-19 Duration of Therapy Humans *Mycobacterium bovis Neoplasm Invasiveness Neoplasm Recurrence Local/drug therapy Network Meta-Analysis Pandemics *Urinary Bladder Neoplasms/drug therapy *Urology
文献简介 原文链接
The Role of Fluorescence In Situ Hybridization in the Surveillance of Non-Muscle Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis

 2022 年发布于 Front Nutr 9 卷第 4 期

Zheng W. Lin T. Chen Z. Cao D. Bao Y. Zhang P. Yang L. Wei Q.

Humans Female Male *Urinary Bladder Neoplasms/etiology/microbiology RNA Ribosomal 16S/genetics Urinary Bladder/microbiology *Microbiota/genetics Bacteria/genetics Bladder cancer Gender Urinary microbiota Uropathogens of interest.
文献简介 原文链接
Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: a meta-analysis

 2022 年发布于 Clinicoeconomics and Outcomes Research 42 卷第 3 期

Rizzo A. Mollica V. Santoni M. Ricci A. D. Gadaleta-Caldarola G. Montironi R. Massari F.

Artificial Intelligence Humans Muscles/pathology ROC Curve Sensitivity and Specificity *Urinary Bladder Neoplasms/diagnostic imaging/pathology Bladder cancer Meta-analysis Muscle invasive Radiomics Staging Systematic review
文献简介 原文链接
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence

 2022 年发布于 Infect Agent Cancer 11 卷第 3 期

Laukhtina E. Abufaraj M. Al-Ani A. Ali M. R. Mori K. Moschini M. Quhal F. Sari Motlagh R. Pradere B. Schuettfort V. M. Mostafaei H. Katayama S. Grossmann N. C. Fajkovic H. Soria F. Enikeev D. Shariat S. F.

Humans *Carcinoma Renal Cell/surgery Prognosis Nutritional Status *Carcinoma Transitional Cell/surgery *Urinary Bladder Neoplasms Nephrectomy *Kidney Neoplasms/surgery Retrospective Studies Controlling Nutritional Status score Renal cell carcinoma Upper tract urothelial carcinoma
文献简介 原文链接

 2022 年 发布于 Int J Nurs Pract 13 卷 第 4 期

Garcia-Rojo D. Munoz-Rodriguez J. Centeno C. Dominguez A. Prera A. Abad C. Vicente E. Gonzalez-Sala J. L. Hannaoui N. Capdevila M. De Verdonces L. Ferran A. Pla C. Azuara P. Cuadrench S. Zegri M. E. Prats J.

 2022 年 发布于 Eur Urol Focus 13 卷 第 5 期

Petzold A. P. Lubianca F. N. Passos L. G. Keppler C. K. Becker N. B. Viera C. D. Fay A. P. Carvalhal G. F.

 2022 年 发布于 Frontiers in Oncology 8 卷 第 17 期

Mori K. Schuettfort V. M. Yanagisawa T. Katayama S. Pradere B. Laukhtina E. Rajwa P. Mostafaei H. Sari Motlagh R. Quhal F. Moschini M. Soria F. Teoh J. Y. C. D'Andrea D. Abufaraj M. Albisinni S. Krajewski W. Egawa S. Karakiewicz P. I. Rink M. Shariat S. F.

 2022 年 发布于 Cancers (Basel) 44 卷 第 10 期

Chen J. Cao D. Peng Z. Song P. Liu Z. Yang L. Wang L. Zhou J. Wei Q. Dong Q.

 2022 年 发布于 Cancers (Basel) 44 卷 第 3 期

Deininger S. Törzsök P. Mitterberger M. Pallauf M. Oswald D. Deininger C. Lusuardi L.

 2022 年 发布于 J Endourol 2022 卷 第 4 期

Rai B. P. Luis Dominguez Escrig J. Vale L. Kuusk T. Capoun O. Soukup V. Bruins H. M. Yuan Y. Violette P. D. Santesso N. van Rhijn B. W. G. Hugh Mostafid A. Imran Omar M.

 2022 年 发布于 Bladder Cancer 81 卷 第 6 期

Yanagisawa T. Mori K. Motlagh R. S. Kawada T. Mostafaei H. Quhal F. Laukhtina E. Rajwa P. Konig F. Pallauf M. Pradere B. D'Andrea D. Comperat E. Miki J. Kimura T. Egawa S. Shariat S. F.

 2022 年 发布于 Urol Oncol 76 卷 第 1 期

Touala-Chaila Z. Abderrahmane R. K. Benseddik K. Meroufel D. N.

 2022 年 发布于 Eur Radiol 2022 卷 第 12 期

Zhang J. Song L. Zhu H. Liu Q. Wang D.

 2022 年 发布于 Arch Ital Urol Androl 13 卷 第 12 期

Oswald D. Pallauf P. Deininger S. Herrmann T. R. W. Netsch C. Becker B. Fiedler M. Haecker A. Homberg R. Klein J. T. Lehrich K. Miernik A. Olbert P. Schob D. S. Sievert K. D. Gross A. J. Westphal J. Lusuardi L.

 2022 年 发布于 Int Braz J Urol 40 卷 第 1 期

Laukhtina E. Shim S. R. Mori K. D'Andrea D. Soria F. Rajwa P. Mostafaei H. Comperat E. Cimadamore A. Moschini M. Teoh J. Y. C. Enikeev D. Xylinas E. Lotan Y. Palou J. Gontero P. Babjuk M. Witjes J. A. Kamat A. M. Roupret M. Shariat S. F. Pradere B.

 2022 年 发布于 European Urology Focus 94 卷 第 5 期

Liu C. Q. Sun J. X. Xu J. Z. Qian X. Y. Hong S. Y. Xu M. Y. An Y. Xia Q. D. Hu J. Wang S. G.

 2022 年 发布于 Anticancer Research 169 卷 第 16 期

Morozov A. Babaevskaya D. Taratkin M. Inoyatov J. Laukhtina E. Moschini M. Singla N. Gomez Rivas J. Teoh J. Y. Glybochko P. Enikeev D.

 2022 年 发布于 Bladder Cancer 2022 卷 第 5 期

Jazayeri S. B. Dehghanbanadaki H. Hosseini M. Taghipour P. Bazargani S. Thomas D. Feibus A. Sarabchian E. Bacchus M. W. Di Valerio E. A. Bandyk M. Balaji K. C.

 2022 年 发布于 Int J Urol 86 卷 第 1 期

Zhou W. Liu J. Mao D. Hu C. Gao D.

 2022 年 发布于 PLoS One 104 卷 第 7 期

Peng L. Meng C. Li J. You C. Du Y. Xiong W. Xia Z. Cao D. Li Y.

 2022 年 发布于 Int Braz J Urol 82 卷 第 7 期

Wang J. Zhao X. Jiang X. L. Lu D. Yuan Q. Li J.

 2022 年 发布于 Front Nutr 9 卷 第 4 期

Zheng W. Lin T. Chen Z. Cao D. Bao Y. Zhang P. Yang L. Wei Q.

 2022 年 发布于 Clinicoeconomics and Outcomes Research 42 卷 第 3 期

Rizzo A. Mollica V. Santoni M. Ricci A. D. Gadaleta-Caldarola G. Montironi R. Massari F.

 2022 年 发布于 Infect Agent Cancer 11 卷 第 3 期

Laukhtina E. Abufaraj M. Al-Ani A. Ali M. R. Mori K. Moschini M. Quhal F. Sari Motlagh R. Pradere B. Schuettfort V. M. Mostafaei H. Katayama S. Grossmann N. C. Fajkovic H. Soria F. Enikeev D. Shariat S. F.

 2022 年发布于 Int J Nurs Pract 13 卷第 4 期

 2022 年发布于 Eur Urol Focus 13 卷第 5 期

 2022 年发布于 Frontiers in Oncology 8 卷第 17 期

 2022 年发布于 Cancers (Basel) 44 卷第 10 期

 2022 年发布于 Cancers (Basel) 44 卷第 3 期

 2022 年发布于 J Endourol 2022 卷第 4 期

 2022 年发布于 Bladder Cancer 81 卷第 6 期

 2022 年发布于 Urol Oncol 76 卷第 1 期

 2022 年发布于 Eur Radiol 2022 卷第 12 期

 2022 年发布于 Arch Ital Urol Androl 13 卷第 12 期

 2022 年发布于 Int Braz J Urol 40 卷第 1 期

 2022 年发布于 European Urology Focus 94 卷第 5 期

 2022 年发布于 Anticancer Research 169 卷第 16 期

 2022 年发布于 Bladder Cancer 2022 卷第 5 期

 2022 年发布于 Int J Urol 86 卷第 1 期

 2022 年发布于 PLoS One 104 卷第 7 期

 2022 年发布于 Int Braz J Urol 82 卷第 7 期

 2022 年发布于 Front Nutr 9 卷第 4 期

 2022 年发布于 Clinicoeconomics and Outcomes Research 42 卷第 3 期

 2022 年发布于 Infect Agent Cancer 11 卷第 3 期